Jae Moon Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jae Moon Bae has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Jun Ho Lee
Research Institute and Hospital, National Cancer Center 809 Madu‐dong, Ilsan‐gu 411‐764 Goyang Gyeonggi Korea
2 shared publicationsKeun Won Ryu
Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, 411-764, Goyang, Gyeonggi, Korea
2 shared publicationsIl Ju Choi
Center for Gastric Cancer, National Cancer Center, Korea
1 shared publicationJoong‐Won Park
Research Institute and Hospital, National Cancer Center 809 Madu‐dong, Ilsan‐gu 411‐764 Goyang Gyeonggi Korea
1 shared publicationYoung Woo Kim
Research Institute and Hospital, National Cancer Center 809 Madu‐dong, Ilsan‐gu 411‐764 Goyang Gyeonggi Korea
1 shared publication
Latest Publications
- 14 April 2005
- Published by Wiley in World Journal of Surgery
- Vol. 29 (5) , 653-656
Management of Ascites after Radical Surgery in Gastric Cancer Patients With Liver Cirrhosis and Minimal Hepatic Dysfunction
A radical lymph node dissection is important for the cure of gastric cancer. However, such a procedure in patients with liver cirrhosis (LC) could develop serious complications such as massive ascites. To determine the management of postoperative ascites, 26 gastric cancer patients with LC were reviewed retrospectively. Child-Pugh status was grade A in all 26 patients. Thirteen (50%) patients had advanced gastric cancer, and a D2 lymph nodes dissection was performed in 25 (96.2%) patients. The mean number of dissected lymph nodes was 33 ± 11 (range: 11–54). An abdominal closed suction drain was placed in 12 (46.2%) patients, and the average amount of fluid drainage was 463 ml/day. The drainage tube was removed on about the eleventh postoperative day (range: day 6 to day 13), and diuretics were used in 8 (30.8%) patients. A paracentesis was needed in one patient but no postoperative surgical morbidity or mortality was observed. Therefore, an extended lymph node dissection is safe in gastric cancer patients with mild hepatic dysfunction. Liver cirrhosis and postoperative ascites can be managed conservatively without any complications.
- 14 April 2005
- Published by Wiley in World Journal of Surgery
- Vol. 29 (5) , 653-656
Management of Ascites after Radical Surgery in Gastric Cancer Patients With Liver Cirrhosis and Minimal Hepatic Dysfunction
A radical lymph node dissection is important for the cure of gastric cancer. However, such a procedure in patients with liver cirrhosis (LC) could develop serious complications such as massive ascites. To determine the management of postoperative ascites, 26 gastric cancer patients with LC were reviewed retrospectively. Child-Pugh status was grade A in all 26 patients. Thirteen (50%) patients had advanced gastric cancer, and a D2 lymph nodes dissection was performed in 25 (96.2%) patients. The mean number of dissected lymph nodes was 33 ± 11 (range: 11–54). An abdominal closed suction drain was placed in 12 (46.2%) patients, and the average amount of fluid drainage was 463 ml/day. The drainage tube was removed on about the eleventh postoperative day (range: day 6 to day 13), and diuretics were used in 8 (30.8%) patients. A paracentesis was needed in one patient but no postoperative surgical morbidity or mortality was observed. Therefore, an extended lymph node dissection is safe in gastric cancer patients with mild hepatic dysfunction. Liver cirrhosis and postoperative ascites can be managed conservatively without any complications.
- 24 December 2002
- Published by Wiley in Journal of Surgical Oncology
- Vol. 82 (1) , 75-77
Preoperative endoscopic clipping: Localizing technique of early gastric cancer
- 24 December 2002
- Published by Wiley in Journal of Surgical Oncology
- Vol. 82 (1) , 75-77
Preoperative endoscopic clipping: Localizing technique of early gastric cancer